Selena Y Ding

Selena Y Ding

Auto-generated profile, based on publicly available information

Selena Y Ding

HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2020 in eLife
Verified
Journal Article
Open access
KRKazi Rahman
Kazi Rahman
CCCharles A Coomer
Charles A Coomer
SMSaliha Majdoul
Saliha Majdoul
SDSelena Y Ding
Selena Y Ding
SPSergi Padilla-Parra
Sergi Padilla-Parra
ACAlex Compton
Alex Compton
The interferon-inducible transmembrane (IFITM) proteins belong to the Dispanin/CD225 family and inhibit diverse virus infections. IFITM3 reduces membrane fusion between cells and virions through a poorly characterized mechanism. Mutation of proline-rich transmembrane protein 2 (PRRT2), a regulator of neurotransmitter release, at glycine-305 was previously linked to paroxysmal neurological disorders in humans. Here, we show that glycine-305 and the homologous site in IFITM3, glycine-95, drive protein oligomerization from within a GxxxG motif. Mutation of glycine-95 (and to a lesser extent, glycine-91) disrupted IFITM3 oligomerization and reduced its antiviral activity against Influenza A virus. An oligomerization-defective variant was used to reveal that IFITM3 promotes membrane rigidity in a glycine-95-dependent and amphipathic helix-dependent manner. Furthermore, a compound which counteracts virus inhibition by IFITM3, Amphotericin B, prevented the IFITM3-mediated rigidification of membranes. Overall, these data suggest that IFITM3 oligomers inhibit virus-cell fusion by promoting membrane rigidity.